Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Delayed Quote. Delayed Xetra - 01/22 11:35:14 am
141.1 EUR   -0.11%
01/22MERCK KGAA : Independant Research sticks Neutral
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : Credit Suisse maintains a Buy rating

11/13/2020 | 09:17am EST

Credit Suisse is positive on the stock with a Buy rating. The target price is increased from EUR 140 to EUR 145.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
CREDIT SUISSE GROUP AG -0.45% 12.18 Delayed Quote.6.84%
MERCK KGAA -0.11% 141.1 Delayed Quote.0.53%
All news about MERCK KGAA
01/22MERCK KGAA : Independant Research sticks Neutral
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
01/21MERCK KGAA : Bernstein remains Neutral
MD
01/21MERCK KGAA : JP Morgan maintains a Buy rating
MD
01/21MERCK KGAA : UBS reaffirms its Neutral rating
MD
01/21MERCK : Discontinues Phase III Clinical Trial For Lung Cancer Drug On Failure To..
MT
01/20MERCK KGAA : Credit Suisse gives a Buy rating
MD
01/20MERCK KGAA : Sell rating from Goldman Sachs
MD
01/20MERCK : Shares Fall After Announcement of Cancer-Drug Trial Interruption
DJ
More news
Financials
Sales 2020 17 362 M 21 128 M 21 128 M
Net income 2020 1 977 M 2 405 M 2 405 M
Net Debt 2020 11 147 M 13 565 M 13 565 M
P/E ratio 2020 31,0x
Yield 2020 0,99%
Capitalization 61 347 M 74 677 M 74 653 M
EV / Sales 2020 4,18x
EV / Sales 2021 3,88x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 139,28 €
Last Close Price 141,10 €
Spread / Highest target 19,8%
Spread / Average Target -1,29%
Spread / Lowest Target -28,4%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA0.53%74 677
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD11.98%27 883
KYOWA KIRIN CO., LTD.-1.28%14 378
BETTA PHARMACEUTICALS CO., LTD.33.28%8 898
YUHAN CORPORATION-3.60%4 265
RECIPHARM AB (PUBL)3.74%2 769